Shares of eXoZymes Inc. (NASDAQ:EXOZ - Get Free Report) were down 2.8% during mid-day trading on Thursday . The stock traded as low as $9.69 and last traded at $9.91. Approximately 1,256 shares were traded during mid-day trading, a decline of 88% from the average daily volume of 10,423 shares. The stock had previously closed at $10.20.
eXoZymes Stock Performance
The company has a 50-day moving average of $12.46.
eXoZymes (NASDAQ:EXOZ - Get Free Report) last released its earnings results on Monday, May 12th. The company reported ($0.22) earnings per share (EPS) for the quarter.
About eXoZymes
(
Get Free Report)
eXoZymes, Inc is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV.
Featured Articles
Before you consider eXoZymes, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and eXoZymes wasn't on the list.
While eXoZymes currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
